PB2554: DESIGN OF A PHASE 1B OPEN-LABEL STUDY TO ASSESS THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT (ALPN-303) IN SUBJECTS WITH AUTOIMMUNE CYTOPENIAS (RUBY-4)

Detalles Bibliográficos
Autores principales: Broome, Catherine M, Arnold, Donald, Piatek, Caroline, Lee, Eun-Ju, Zayed, Hany, Peng, Stanford, Simsek, Ismail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429011/
http://dx.doi.org/10.1097/01.HS9.0000976912.69182.0b

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429011/
http://dx.doi.org/10.1097/01.HS9.0000976912.69182.0b

Ejemplares similares